Abstract:Thiamine deficiency (TD) is accepted as the cause of beriberi because of its action in the metabolism of simple carbohydrates, mainly as the rate limiting cofactor for the dehydrogenases of pyruvate and alpha-ketoglutarate, both being critical to the action of the citric acid cycle. Transketolase, dependent on thiamine and magnesium, occurs twice in the oxidative pentose pathway, important in production of reducing equivalents. Thiamine is also a cofactor in the dehydrogenase complex in the degradation of the branched chain amino acids, leucine, isoleucine and valine. In spite of these well accepted facts, the overall clinical effects of TD are still poorly understood. Because of the discovery of 2-hydroxyacyl-CoA lyase (HACL1) as the first peroxisomal enzyme in mammals found to be dependent on thiamine pyrophosphate (TPP) and the ability of thiamine to bind with prion protein, these factors should improve our clinical approach to TD. HACL1 has two important roles in alpha oxidation, the degradation of phytanic acid and shortening of 2-hydroxy long-chain fatty acids so that they can be degraded further by beta oxidation. The downstream effects of a lack of efficiency in this enzyme would be expected to be critical in normal brain metabolism. Although TD has been shown experimentally to produce reversible damage to mitochondria and there are many other causes of mitochondrial dysfunction, finding TD as the potential biochemical lesion would help in differential diagnosis. Stresses imposed by infection, head injury or inoculation can initiate intermittent cerebellar ataxia in thiamine deficiency/dependency. Medication or vaccine reactions appear to be more easily initiated in the more intelligent individuals when asymptomatic marginal malnutrition exists. Erythrocyte transketolase testing has shown that thiamine deficiency is widespread. It is hypothesized that the massive consumption of empty calories, particularly those derived from carbohydrate and fat, results in a high calorie/thiamine ratio as a major cause of disease. Because mild to moderate TD results in pseudo hypoxia in the limbic system and brainstem, emotional and stress reflexes of the autonomic nervous system are stimulated and exaggerated, producing symptoms often diagnosed as psychosomatic disease. If the biochemical lesion is recognized at this stage, the symptoms are easily reversible. If not, and the malnutrition continues, neurodegeneration follows and results in a variety of chronic brain diseases. Results from acceptance of the hypothesis could be tested by performing erythrocyte transketolase tests to pick out those with TD and supplementing the affected individuals with the appropriate dietary supplements.

Low expression of thiamine pyrophosphokinase-1 contributes to brain susceptibility to thiamine deficiency

Reduced Thiamine Binding is a Novel Mechanism for TPK Deficiency Disorder.

Thiamine pyrophosphokinase deficiency induces Alzheimer’s pathology

Decreased Activity of Transketolase is Related With Regionally Selective Damage of Brain Midline in Wernicke Encephalopathy

P1‐078: Reduced Thiamine Diphosphate Level Contributes to Brain Glucose Hypometabolism and Neurodegeneration in Alzheimer's Disease

Thiamine pyrophosphokinase-1 deficiency in neurons drives Alzheimer's multiple pathophysiological alterations

Decreased Transketolase Activity Contributes to Impaired Hippocampal Neurogenesis Induced by Thiamine Deficiency.

Impairment of Thiamine Transport at the GUT-BBB-AXIS Contributes to Wernicke's Encephalopathy

Thiamine Deficiency Modulates p38MAPK and Heme Oxygenase-1 in Mouse Brain: Association with Early Tissue and Behavioral Changes

Thiamine Metabolism is Critical for Regulating Correlated Growth of Dendrite Arbors and Neuronal Somata.

Thiamine Deficiency Contributes to Synapse and Neural Circuit Defects

Utility of Whole Blood Thiamine Pyrophosphate Evaluation in TPK1-Related Diseases

Thiamine and magnesium deficiencies: keys to disease

Exposure to Pyrithiamine Increases β-Amyloid Accumulation, Tau Hyperphosphorylation, and Glycogen Synthase Kinase-3 Activity in the Brain

Thiamine Diphosphate Reduction Strongly Correlates with Brain Glucose Hypometabolism in Alzheimer’s Disease, Whereas Amyloid Deposition Does Not

Posttranslational Acylations of the Rat Brain Transketolase Discriminate the Enzyme Responses to Inhibitors of ThDP-Dependent Enzymes or Thiamine Transport

SLC19A1 Genetic Variation Leads to Altered Thiamine Diphosphate Transport: Implications for the Risk of Developing Wernicke-Korsakoff's Syndrome

Enhanced Activities Of Blood Thiamine Diphosphatase And Monophosphatase In Alzheimer'S Disease

Downregulation of Transketolase Activity is Related to Inhibition of Hippocampal Progenitor Cell Proliferation Induced by Thiamine Deficiency.

The mechanism and consequences of amyloid-β modulating thiamine pyrophosphokinase-1 expression in microglia

High Thiamine Diphosphate Level As a Protective Factor for Alzheimer's Disease.